The Bulgarian Society of Interventional Cardiology’s journal Interventional Cardiology Forum now boasts an improved publishing infrastructure after moving to the technologically advanced ARPHA Platform, developed by scholarly publisher and technology provider Pensoft. This is the second cardiology journal to move on to ARPHA, after Bulgarian Cardiologydid so last year.
The official organ of The Bulgarian Society of Interventional Cardiology (BulSIC), Interventional Cardiology Forum popularizes scientific achievements in the rapidly developing, highly innovative field of interventional cardiology, which deals specifically with catheter-based treatment of heart diseases and including diagnosis and treatment of coronary artery disease, vascular disease and acquired structural heart disease. The journal provides a platform for the presentation of personal experience, ideas, discussions, and new techniques, devices and materials for catheterization laboratories.
Opting for ARPHA’s white-label solution, Interventional Cardiology Forum will benefit from ARPHA’s services while publishing under BulSIC’s branding and imprint. The journal is already enjoying a brand-new, user-friendly website under Pensoft’s scholarly publishing platform. Furthermore, it takes advantage of ARPHA’s signature fast-track publishing system, which offers an end-to-end solution from submission to publication, distribution and archiving. Providing a synergic online space for submission, reviewing, editing, production and archiving, ARPHA ensures a seamlessly integrated workflow at every step of the publishing process.
Interventional Cardiology Forum is the third journal in ARPHA’s universe to opt for bilingual publishing after Bulgaria’s National Cardiac Society’s Bulgarian Cardiology and Moscow State University’s Population and Economics. At Interventional Cardiology Forum, authors can publish their papers in either Bulgarian or both Bulgarian and English, where bilingual papers are displayed in both languages side by side.